Strategic Silence: Why the Most Impactful Experts Aren’t Always the Most Vocal
Volume isn’t the same as influence. Some Key External Experts shape clinical thinking without posting daily threads or dominating conference panels. They […]
Building an Expert Universe: Connecting the Dots Between Influence, Behavior & Reach
Identifying and engaging Key Opinion Leaders (KOLs) requires more than just counting followers or publication citations. With rapid digitalization and innovation in
Social Media to Strategic Plans: DOL Engagement That Works
Digital Opinion Leaders (DOLs) have emerged as critical partners for healthcare organizations seeking to amplify scientific insights, foster clinician trust,
Real-Time Social Listening for Competitive Strategy
Effective competitive strategy in healthcare hinges on timely, actionable insights. Traditional market research (sales data, prescription volumes, and clinical trial
The Underrated Power of KEE Sentiment in Shaping Brand Perception
Effective brand management in healthcare requires more than clinical data and sales metrics. Key Opinion Experts (KEEs), clinicians, researchers, and specialized practitioners
How KOL Mapping Strengthens Your Pre-Launch Strategy
In today’s competitive pharmaceutical landscape, a product’s success doesn’t start at launch—it begins long before. The launch strategy sets the
AI-Powered KOL Mapping: Scaling Engagement with Precision and Personalization
The way the competitive pharma industry is set up today, success doesn’t start post-launch; it starts well before launch. By
Mining the Right Insights: How Pharma Companies Can Leverage Data for Competitive Advantage
Imagine launching a new drug only to realize that it’s struggling in the market due to poor adoption by physicians
Optimizing KOL Engagement in Pharma with AI-Powered Solutions
The Critical Role of KOL Engagement in Pharma Key Opinion Leaders (KOLs) are pivotal in driving scientific innovation, regulatory approvals,
Next Gen KOL Research and Management
The Rapid evolution of technology has pushed every industry in a state of flux. The pharmaceutical industry is no exception